Literature DB >> 18513744

Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase.

Beibei Luo1, Carol Norris, Erin S D Bolstad, David A Knecht, David F Grant.   

Abstract

The peroxisomal targeting sequence 1 (PTS1) is a consensus tripeptide 1 (S/C/A)(K/R/H)(L/M) that is found at the C-terminus of most peroxisomal proteins. However, the only known mammalian protein containing a terminal methionine PTS1 (SKM), human soluble epoxide hydrolase (hsEH), shows both peroxisomal and cytosolic localizations in vivo. Mechanisms regulating the subcellular localization of hsEH thus remain unclear. Here we utilized green fluorescent protein-hsEH fusion constructs to study the peroxisomal targeting of hsEH in transiently and stably transfected Chinese hamster ovary cells. Our results suggest that the peroxisomal import of hsEH is regulated by three factors. First, we show that SKM is required, but not sufficient, for peroxisomal import. Second, by manipulating protein expression levels, we show that SKM mediates peroxisomal import of wild-type hsEH only when expression levels are high. Third, we show that amino acid modifications that decrease subunit oligomerization and presumably enhance accessibility of the SKM motif confer peroxisomal targeting even at low protein expression levels. We conclude that, in hsEH, SKM is a necessary but inefficient and context-dependent PTS1. Peroxisomal import occurs when expression levels are high or when the SKM motif is accessible. These results provide a mechanistic basis for understanding the cell-specific and tissue-specific localization of hsEH in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513744      PMCID: PMC2515390          DOI: 10.1016/j.jmb.2008.04.064

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  56 in total

Review 1.  Import of peroxisomal matrix and membrane proteins.

Authors:  S Subramani; A Koller; W B Snyder
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.

Authors:  Xiang Fang; Shanming Hu; Bingkun Xu; Gary D Snyder; Shawn Harmon; Jianrong Yao; Yi Liu; Bhavani Sangras; J R Falck; Neal L Weintraub; Arthur A Spector
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-08-19       Impact factor: 4.733

3.  The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

Authors:  Myriam Fornage; Craig R Lee; Peter A Doris; Molly S Bray; Gerardo Heiss; Darryl C Zeldin; Eric Boerwinkle
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

4.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

5.  Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.

Authors:  German A Gomez; Christophe Morisseau; Bruce D Hammock; David W Christianson
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

6.  Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.

Authors:  Ahmed E Enayetallah; David F Grant
Journal:  Biochem Biophys Res Commun       Date:  2006-01-10       Impact factor: 3.575

7.  Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.

Authors:  Kentaro Ohtoshi; Hideaki Kaneto; Koichi Node; Yumiko Nakamura; Toshihiko Shiraiwa; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

8.  The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.

Authors:  Yi Liu; Yingjia Zhang; Kara Schmelzer; Tzong-Shyuan Lee; Xiang Fang; Yi Zhu; Arthur A Spector; Sarjeet Gill; Christophe Morisseau; Bruce D Hammock; John Y-J Shyy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

9.  Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.

Authors:  Ahmed E Enayetallah; Richard A French; Michele Barber; David F Grant
Journal:  J Histochem Cytochem       Date:  2005-11-28       Impact factor: 2.479

10.  The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.

Authors:  Annette Cronin; Sherry Mowbray; Heike Dürk; Shirli Homburg; Ingrid Fleming; Beate Fisslthaler; Franz Oesch; Michael Arand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more
  17 in total

1.  PEX5 protein binds monomeric catalase blocking its tetramerization and releases it upon binding the N-terminal domain of PEX14.

Authors:  Marta O Freitas; Tânia Francisco; Tony A Rodrigues; Inês S Alencastre; Manuel P Pinto; Cláudia P Grou; Andreia F Carvalho; Marc Fransen; Clara Sá-Miranda; Jorge E Azevedo
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

2.  Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.

Authors:  Xiaocui Qin; Qiaoqi Wu; Lifang Lin; Aimin Sun; Shuhu Liu; Xiaowen Li; Xiong Cao; Tianming Gao; Pengcheng Luo; Xinhong Zhu; Xuemin Wang
Journal:  Mol Neurobiol       Date:  2014-08-17       Impact factor: 5.590

3.  Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

Authors:  Jonathan W Nelson; Jennifer M Young; Rohan N Borkar; Randy L Woltjer; Joseph F Quinn; Lisa C Silbert; Marjorie R Grafe; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-30       Impact factor: 3.072

Review 4.  Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

5.  Peroxisomal localisation of the final steps of the mevalonic acid pathway in planta.

Authors:  Andrew J Simkin; Grégory Guirimand; Nicolas Papon; Vincent Courdavault; Insaf Thabet; Olivia Ginis; Sadok Bouzid; Nathalie Giglioli-Guivarc'h; Marc Clastre
Journal:  Planta       Date:  2011-06-08       Impact factor: 4.116

6.  Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury.

Authors:  Jonathan W Nelson; Wenri Zhang; Nabil J Alkayed; Ines P Koerner
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

7.  Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.

Authors:  Christophe Morisseau; Aaron T Wecksler; Catherine Deng; Hua Dong; Jun Yang; Kin Sing S Lee; Sean D Kodani; Bruce D Hammock
Journal:  J Lipid Res       Date:  2014-04-27       Impact factor: 5.922

8.  Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase.

Authors:  Ahmed E EnayetAllah; Ayala Luria; Beibei Luo; Hsing-Ju Tsai; Priyanka Sura; Bruce D Hammock; David F Grant
Journal:  J Biol Chem       Date:  2008-10-29       Impact factor: 5.157

9.  Molecular requirements for peroxisomal targeting of alanine-glyoxylate aminotransferase as an essential determinant in primary hyperoxaluria type 1.

Authors:  Krisztián Fodor; Janina Wolf; Ralf Erdmann; Wolfgang Schliebs; Matthias Wilmanns
Journal:  PLoS Biol       Date:  2012-04-17       Impact factor: 8.029

10.  Predicted mouse peroxisome-targeted proteins and their actual subcellular locations.

Authors:  Yumi Mizuno; Igor V Kurochkin; Marlis Herberth; Yasushi Okazaki; Christian Schönbach
Journal:  BMC Bioinformatics       Date:  2008-12-12       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.